The use of serum neutralizing antibody assay for the determination of the potency of foot and mouth disease (FMD) vaccines in cattle
- PMID: 3025036
The use of serum neutralizing antibody assay for the determination of the potency of foot and mouth disease (FMD) vaccines in cattle
Abstract
The Permanent Commission of O.I.E. on foot and mouth disease has proposed a series of potency standards for foot and mouth disease vaccines. No totally in vitro assay has yet been developed to satisfy these requirements, and most Control Authorities require a potency assay to be carried out in cattle using challenge with virulent virus. There are various reasons why challenge tests should be replaced by serological tests, but a stumbling block to this is the requirement that the 50% protective antibody level (PA50) is valid only for a specific combination of vaccine virus seed lot with cattle virus seed lot in a laboratory. The results of challenge and antibody tests for 38 U.K. Control Authority vaccine batch tests were analysed to examine the correlation between potencies measured by the two methods. The correlation between the methods was high and the proportion of misclassification of batches was low. It is suggested that the results provide a good basis for future use of the serological method, but that it is still sometimes necessary to carry out challenge tests.
Similar articles
-
Selection of foot and mouth disease vaccine strains--a review.Rev Sci Tech. 2005 Dec;24(3):981-93. Rev Sci Tech. 2005. PMID: 16642769 Review.
-
Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina.Vaccine. 2008 Dec 2;26(51):6577-86. doi: 10.1016/j.vaccine.2008.09.033. Vaccine. 2008. PMID: 18835312
-
High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.Vaccine. 2008 Mar 20;26(13):1681-7. doi: 10.1016/j.vaccine.2008.01.038. Epub 2008 Feb 12. Vaccine. 2008. PMID: 18313814
-
Reduction of animal usage in the control of foot-and-mouth disease vaccines.Dev Biol Stand. 1986;64:163-7. Dev Biol Stand. 1986. PMID: 3025037
-
Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination.Rev Sci Tech. 2007 Apr;26(1):117-34. Rev Sci Tech. 2007. PMID: 17633297 Review.
Cited by
-
An antigen panel to assess the regional relevance of foot and mouth disease vaccines.NPJ Vaccines. 2025 May 26;10(1):106. doi: 10.1038/s41541-025-01128-7. NPJ Vaccines. 2025. PMID: 40419503 Free PMC article.
-
Preparation and application of porcine broadly neutralizing monoclonal antibodies in an immunoassay for efficiently detecting neutralizing antibodies against foot-and-mouth disease virus serotype O.Microbiol Spectr. 2025 Feb 4;13(2):e0223424. doi: 10.1128/spectrum.02234-24. Epub 2025 Jan 8. Microbiol Spectr. 2025. PMID: 39772731 Free PMC article.
-
System immunology-based identification of blood transcriptional modules correlating to antibody responses in sheep.NPJ Vaccines. 2018 Oct 3;3:41. doi: 10.1038/s41541-018-0078-0. eCollection 2018. NPJ Vaccines. 2018. PMID: 30302283 Free PMC article.
-
Implication of Broadly Neutralizing Bovine Monoclonal Antibodies in the Development of an Enzyme-Linked Immunosorbent Assay for Detecting Neutralizing Antibodies against Foot-and-Mouth Disease Virus Serotype O.J Clin Microbiol. 2019 Nov 22;57(12):e01030-19. doi: 10.1128/JCM.01030-19. Print 2019 Dec. J Clin Microbiol. 2019. PMID: 31578261 Free PMC article.
-
Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review.Vet Res. 2009 May-Jun;40(3):13. doi: 10.1051/vetres:2008051. Epub 2008 Dec 2. Vet Res. 2009. PMID: 19040829 Free PMC article. Review.